Effect of Acceptance and Commitment Therapy on Psychotic Severity

Port Said University

Status: Active, not recruiting

Conditions: Psychosis; Emotion Regulation; Recovery

Treatments: Combination Product: Treatment as usual; Behavioral: Acceptance and commitment therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT06160869

P.0553

Details and patient eligibility

About

Our study aims to assess the efficacy of Acceptance and Commitment Therapy on psychotic severity among Inpatients with primary psychosis: A Randomized Controlled Trial.

Full description

Current study was an open label, two-arm, parallel, randomized controlled trial, evaluating the efficiency of Acceptance and Commitment Therapy (ACT) added to treatment as usual (TAU) as opposed to treatment as usual (TAU) alone on patients with schizophrenia. The study adheres to the rules for writing Clinical Trials: "The Consolidated Standards of Reporting Trials" (CONSORT) statement

Enrollment: 76 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria Participants' criteria of inclusion involved those patients who were

1. Current psychiatric hospitalization;
2. DSM-5 diagnosis of a primary psychotic disorder; (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder, brief psychotic disorder, and unspecified psychotic disorder, this diagnosis was confirmed by a psychiatrist
3. 18 years or older;
4. ability to talk, read and write in Arabic; and
5. willingness to participate in the study that was scheduled for seven weeks.

Exclusion criteria Patients were excluded if they

1. had a comorbid learning disability or organic brain disorder;
2. psychosis related to a general medical condition or substance-induced psychotic disorder;
3. were considered mentally unstable; or
4. unfit to participate in the study by their therapist, and/or had newly had (been receiving) psycho-education or somewhat designed psychosocial intervention.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

76 participants in 2 patient groups

ACT Group

Experimental group

Description:

Received 90-minutes weekly group sessions of acceptence and commitment therapy plus treatment as usual.

Treatment:

Behavioral: Acceptance and commitment therapy

Treatment as usual (TAU) group

Active Comparator group

Description:

Will receive the TAU alone

Treatment:

Combination Product: Treatment as usual